Ikeda Yasuo | Division Of Hematology Keio University School Of Medicine
スポンサーリンク
概要
Division Of Hematology Keio University School Of Medicine | 論文
- Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma : Prognostic factors and unique toxicity profile
- Thalidomide-Induced Severe Neutropenia during Treatment of Multiple Myeloma
- Recurrence of Autoimmune Disease after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
- Thalidomide for the Treatment of Refractory Multiple Myeloma : Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome
- Elevated Level of Plasma Basic Fibroblast Growth Factor in Multiple Myeloma Correlates with Increased Disease Activity